The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease

Falcone C., Geroldi D., Buzzia M. P., Ernanuele E., YILMAZ Y., Fontana J. M., ...Daha Fazla

ARCHIVES OF MEDICAL RESEARCH, cilt.39, sa.3, ss.320-325, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 3
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.arcmed.2007.11.003
  • Dergi Adı: ARCHIVES OF MEDICAL RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.320-325
  • Bursa Uludağ Üniversitesi Adresli: Hayır

Özet

Background. The -374T/A polymorphism of the Receptor for Advanced Glycation End products (RAGE) may exert a protective effect toward the development of atherosclerosis. No data are currently available on the potential prognostic role of this polymorphism in patients with angiographically proven coronary artery disease (CAD). Hereto we sought to address this issue in a large consecutive cohort of patients undergoing coronary revascularization.